Newlink Genetics reported 7.84M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US $ 61.4M 12.89M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Capricor Therapeutics CAPR:US $ 7.83M 1.44M
Celldex Therapeutics CLDX:US $ 36.56M 13.13M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Idera Pharmaceuticals IDRA:US $ 4.18M 61K
Intrexon XON:US $ 49.92M 5.21M
Merk MRK:US $ 9666M 666M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Newlink Genetics NLNK:US 7.84M 1.05M
Pfizer PFE:US $ 15640M 148M
Prothena PRTA:US 44.52M 5.42M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Vascular Biogenics VBLT:US 10.68M 1.37M
YTE INCY:US $ 656.97M 40.27M